Mumbai, India 22nd April, 2025: Remedium Lifecare Limited (BSE: 539561) has announced the strategic objectives of its upcoming rights issue, recently approved by the Bombay Stock Exchange (BSE). This capital raise is a cornerstone of the company’s transformation into a vertically integrated, research-driven pharmaceutical player, aimed at accelerating global expansion and strengthening operational capabilities. Remedium […]
The post Remedium Lifecare Announces Rights Issue After ₹182.7 Cr UK Deal for Global Growth first appeared on Business News Week.